Tracking the Long-Term journey of kids battling skin cancer
NCT ID NCT04196452
Summary
This study is looking back at the medical records of children in the Netherlands who were treated for advanced melanoma with a drug called ipilimumab. The goal is to understand the long-term side effects, survival rates, and overall health outcomes for these young patients. It is an observational study, meaning researchers are collecting information but not testing a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.